Inactive Instrument

Press Releases ALPA HEAL

Equities

ALPA

US02073F1049

Press Releases

Unlock all the news: Be the first to know and act before the market!

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary	Mar. 20	AQ
Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field	Mar. 18	AQ
Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024	Feb. 26	AQ
Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors	Nov. 16	AQ
ALPA HEAL : Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors - Form 8-K	Nov. 16	PU
Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics	23-09-05	AQ
ALPA HEAL : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	23-07-20	PU
Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation	23-07-17	AQ
Alpha Healthcare Acquisition Corp. III Announces Successful Closing of Business Combination with Carmell Therapeutics Corporation	23-07-14	BU
Alpha Healthcare Acquisition III : Material Agreement - Form 8-K	23-07-10	PU
Carmell Therapeutics Merger With Alpha Healthcare Acquisition Corp III (Nasdaq: ALPA) July 6, 2023 - Form 8-K	23-07-06	PU
Alpha Healthcare Acquisition Corp. III Announces Non-Binding Letter of Intent to Acquire a Commercial Stage Regenerative Medicine Company Conditioned Upon Closing of Carmell Business Combination	23-06-27	BU
ALPHA HEALTHCARE ACQUISITION CORP III : Other Events (form 8-K)	23-05-02	AQ
ALPHA HEALTHCARE ACQUISITION CORP III : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	23-03-31	AQ
ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	23-03-17	AQ
Alpha Healthcare Acquisition Corp. III Announces Merger with Carmell Therapeutics, a Phase 2 Stage Biotechnology Platform Company Developing Allogeneic Plasma-based Biomaterials for Bone and Soft Tissue Healing Indications	23-01-04	BU
ALPHA HEALTHCARE ACQUISITION CORP III : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-01-04	AQ
ALPHA HEALTHCARE ACQUISITION CORP III Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-11-10	AQ
Alpha Healthcare Acquisition III : Change in Certifying Accountants - Form 8-K	22-10-11	PU
ALPHA HEALTHCARE ACQUISITION CORP III : Changes in Registrant's Certifying Accountant (form 8-K)	22-10-11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ALPA HEAL

Equities

ALPA

US02073F1049

Press Releases

Filters